Hesperidin-3′- O -methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness

You Lan Yang, Hsin Te Hsu, Kuo Hsien Wang, Chao Sian Wang, Chien Ming Chen, Wun-Chang Ko

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hesperidin is present in the traditional Chinese medicine, "Chen Pi," and recently was reported to have anti-inflammatory effects. Therefore, we were interested in comparing the effects of hesperidin and hesperidin-3′-O-methylether on phosphodiesterase inhibition and airway hyperresponsiveness (AHR) in a murine model of asthma. In the present results, hesperidin-3′-O-methylether, but not hesperidin, at 30 mol/kg (p.o.) significantly attenuated the enhanced pause (P enh) value, suppressed the increases in numbers of total inflammatory cells, macrophages, lymphocytes, neutrophils, and eosinophils, suppressed total and OVA-specific immunoglobulin (Ig)E levels in the serum and BALF, and enhanced the level of total IgG 2 a in the serum of sensitized and challenged mice, suggesting that hesperidin-3′-O-methylether is more potent than hesperidin in suppression of AHR and immunoregulation. The different potency between them may be due to their aglycons, because these two flavanone glycosides should be hydrolyzed by β-glucosidase after oral administration. Neither influenced xylazine/ketamine-induced anesthesia, suggesting that they may have few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion. In conclusion, hesperidin-3′-O-methylether is more potent in phosphodiesterase inhibition and suppression of AHR and has higher therapeutic (PDE 4 H / PDE 4 L) ratio than hesperidin. Thus, hesperidin-3′-O- methylether may have more potential for use in treating allergic asthma and chronic obstructive pulmonary disease.

Original languageEnglish
Article number908562
JournalEvidence-based Complementary and Alternative Medicine
Volume2012
DOIs
Publication statusPublished - 2012

Fingerprint

Hesperidin
Ovalbumin
Phosphoric Diester Hydrolases
Asthma
Glucosidases
Xylazine
Chinese Traditional Medicine
Ketamine
Glycosides
Serum
Eosinophils
Chronic Obstructive Pulmonary Disease
Nausea
Immunoglobulin E
Vomiting
Oral Administration
Stomach
Neutrophils
Anti-Inflammatory Agents
Anesthesia

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Hesperidin-3′- O -methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness. / Yang, You Lan; Hsu, Hsin Te; Wang, Kuo Hsien; Wang, Chao Sian; Chen, Chien Ming; Ko, Wun-Chang.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2012, 908562, 2012.

Research output: Contribution to journalArticle

@article{ba95835742e548ca8d09456de932cbde,
title = "Hesperidin-3′- O -methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness",
abstract = "Hesperidin is present in the traditional Chinese medicine, {"}Chen Pi,{"} and recently was reported to have anti-inflammatory effects. Therefore, we were interested in comparing the effects of hesperidin and hesperidin-3′-O-methylether on phosphodiesterase inhibition and airway hyperresponsiveness (AHR) in a murine model of asthma. In the present results, hesperidin-3′-O-methylether, but not hesperidin, at 30 mol/kg (p.o.) significantly attenuated the enhanced pause (P enh) value, suppressed the increases in numbers of total inflammatory cells, macrophages, lymphocytes, neutrophils, and eosinophils, suppressed total and OVA-specific immunoglobulin (Ig)E levels in the serum and BALF, and enhanced the level of total IgG 2 a in the serum of sensitized and challenged mice, suggesting that hesperidin-3′-O-methylether is more potent than hesperidin in suppression of AHR and immunoregulation. The different potency between them may be due to their aglycons, because these two flavanone glycosides should be hydrolyzed by β-glucosidase after oral administration. Neither influenced xylazine/ketamine-induced anesthesia, suggesting that they may have few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion. In conclusion, hesperidin-3′-O-methylether is more potent in phosphodiesterase inhibition and suppression of AHR and has higher therapeutic (PDE 4 H / PDE 4 L) ratio than hesperidin. Thus, hesperidin-3′-O- methylether may have more potential for use in treating allergic asthma and chronic obstructive pulmonary disease.",
author = "Yang, {You Lan} and Hsu, {Hsin Te} and Wang, {Kuo Hsien} and Wang, {Chao Sian} and Chen, {Chien Ming} and Wun-Chang Ko",
year = "2012",
doi = "10.1155/2012/908562",
language = "English",
volume = "2012",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Hesperidin-3′- O -methylether is more potent than hesperidin in phosphodiesterase inhibition and suppression of ovalbumin-induced airway hyperresponsiveness

AU - Yang, You Lan

AU - Hsu, Hsin Te

AU - Wang, Kuo Hsien

AU - Wang, Chao Sian

AU - Chen, Chien Ming

AU - Ko, Wun-Chang

PY - 2012

Y1 - 2012

N2 - Hesperidin is present in the traditional Chinese medicine, "Chen Pi," and recently was reported to have anti-inflammatory effects. Therefore, we were interested in comparing the effects of hesperidin and hesperidin-3′-O-methylether on phosphodiesterase inhibition and airway hyperresponsiveness (AHR) in a murine model of asthma. In the present results, hesperidin-3′-O-methylether, but not hesperidin, at 30 mol/kg (p.o.) significantly attenuated the enhanced pause (P enh) value, suppressed the increases in numbers of total inflammatory cells, macrophages, lymphocytes, neutrophils, and eosinophils, suppressed total and OVA-specific immunoglobulin (Ig)E levels in the serum and BALF, and enhanced the level of total IgG 2 a in the serum of sensitized and challenged mice, suggesting that hesperidin-3′-O-methylether is more potent than hesperidin in suppression of AHR and immunoregulation. The different potency between them may be due to their aglycons, because these two flavanone glycosides should be hydrolyzed by β-glucosidase after oral administration. Neither influenced xylazine/ketamine-induced anesthesia, suggesting that they may have few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion. In conclusion, hesperidin-3′-O-methylether is more potent in phosphodiesterase inhibition and suppression of AHR and has higher therapeutic (PDE 4 H / PDE 4 L) ratio than hesperidin. Thus, hesperidin-3′-O- methylether may have more potential for use in treating allergic asthma and chronic obstructive pulmonary disease.

AB - Hesperidin is present in the traditional Chinese medicine, "Chen Pi," and recently was reported to have anti-inflammatory effects. Therefore, we were interested in comparing the effects of hesperidin and hesperidin-3′-O-methylether on phosphodiesterase inhibition and airway hyperresponsiveness (AHR) in a murine model of asthma. In the present results, hesperidin-3′-O-methylether, but not hesperidin, at 30 mol/kg (p.o.) significantly attenuated the enhanced pause (P enh) value, suppressed the increases in numbers of total inflammatory cells, macrophages, lymphocytes, neutrophils, and eosinophils, suppressed total and OVA-specific immunoglobulin (Ig)E levels in the serum and BALF, and enhanced the level of total IgG 2 a in the serum of sensitized and challenged mice, suggesting that hesperidin-3′-O-methylether is more potent than hesperidin in suppression of AHR and immunoregulation. The different potency between them may be due to their aglycons, because these two flavanone glycosides should be hydrolyzed by β-glucosidase after oral administration. Neither influenced xylazine/ketamine-induced anesthesia, suggesting that they may have few or no adverse effects, such as nausea, vomiting, and gastric hypersecretion. In conclusion, hesperidin-3′-O-methylether is more potent in phosphodiesterase inhibition and suppression of AHR and has higher therapeutic (PDE 4 H / PDE 4 L) ratio than hesperidin. Thus, hesperidin-3′-O- methylether may have more potential for use in treating allergic asthma and chronic obstructive pulmonary disease.

UR - http://www.scopus.com/inward/record.url?scp=84874866580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874866580&partnerID=8YFLogxK

U2 - 10.1155/2012/908562

DO - 10.1155/2012/908562

M3 - Article

C2 - 23082087

AN - SCOPUS:84874866580

VL - 2012

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 908562

ER -